- Home
- NBHC vs KNSA Comparison
NBHC vs KNSA Comparison
Compare NBHC & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBHC
- KNSA
- Stock Information
- Founded
- NBHC 2009
- KNSA 2015
- Country
- NBHC United States
- KNSA United Kingdom
- Employees
- NBHC N/A
- KNSA N/A
- Industry
- NBHC Major Banks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- NBHC Finance
- KNSA Health Care
- Exchange
- NBHC Nasdaq
- KNSA Nasdaq
- Market Cap
- NBHC 1.8B
- KNSA 1.4B
- IPO Year
- NBHC 2012
- KNSA 2018
- Fundamental
- Price
- NBHC $44.09
- KNSA $18.54
- Analyst Decision
- NBHC Hold
- KNSA Strong Buy
- Analyst Count
- NBHC 5
- KNSA 5
- Target Price
- NBHC $51.40
- KNSA $36.60
- AVG Volume (30 Days)
- NBHC 197.0K
- KNSA 485.3K
- Earning Date
- NBHC 01-22-2025
- KNSA 02-26-2025
- Dividend Yield
- NBHC 2.63%
- KNSA N/A
- EPS Growth
- NBHC N/A
- KNSA N/A
- EPS
- NBHC 3.23
- KNSA N/A
- Revenue
- NBHC $401,662,000.00
- KNSA $384,098,000.00
- Revenue This Year
- NBHC N/A
- KNSA $60.05
- Revenue Next Year
- NBHC $6.74
- KNSA $36.74
- P/E Ratio
- NBHC $13.65
- KNSA N/A
- Revenue Growth
- NBHC N/A
- KNSA 54.41
- 52 Week Low
- NBHC $32.13
- KNSA $16.56
- 52 Week High
- NBHC $51.76
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- NBHC 51.03
- KNSA 35.62
- Support Level
- NBHC $43.20
- KNSA $17.82
- Resistance Level
- NBHC $44.93
- KNSA $19.05
- Average True Range (ATR)
- NBHC 1.06
- KNSA 0.63
- MACD
- NBHC 0.27
- KNSA -0.08
- Stochastic Oscillator
- NBHC 78.89
- KNSA 26.09
About NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit card, wire transfer, automated clearing house, and electronic bill payments.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.